SPAC targets in the healthcare space typically are a few years away from full commercialization, but shareholders in Exelfin Acquisition Corp. (NASDAQ:XFIN) will get to vote this week on a combination with a medical device company that is already churning out positive EBITDA.
This week, we speak with Brian Sun, Chief Operating Officer of Excelfin and David Kaysen, Senior Advisor and Chief Marketing Officer for Baird Medical.
The two announced a $279 million dollar combination in June 2023. Brian explains why Excelfin diverted its initial focus from fintech to medical devices.
David lays out how Baird has gotten this far through commercialization in China and why it expects successful adoption in the US. With the prospect of tariffs potentially increasing between those two jurisdictions, they also explain how Baird and Excelfin have a plan for that as well.
LightWave (NASDAQ:LWACU) has filed for a $150 million SPAC with a team of technology specialists and a Board that has advised many SPACs in the CF series. The new SPAC breaks a streak of seven straight new S-1s filed for vehicles with rights and no warrants in their units. LightWave’s units are to each contain...
SPACInsider contributor Henrique Santa Rosa this week compiled his three favorite potential SPAC targets among potential targets in Brazil. We look at why they are compelling and why each could be a fit for a blank-check merger. Brazil is both South America’s largest economy and most populous, making it a ripe target for SPACs. But,...
At the SPAC of Dawn Welsbach Technology Metals (OTC:WTMA) have given some extra reading material for shareholders ahead of its vote to approve its combination with Evolution Metals next month in the form of the duo’s first investor presentation for the deal. The presentation details Evolution’s plan to build up a rare earth processing facility...
At the SPAC of Dawn A busy week of Fed speaking engagements is set to follow this week after Moody’s late Friday downgrade of US debt, which has left markets in the red through the weekend. SPACs may dodge some of the early fallout from the from the switch from AAA to AA1, as none...
Terms Tracker for the Week Ending May 16, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. It was a very, very good week for SPAC IPO trading performances. The average performance for just this week alone clocked in at an average...